📖
Bolus-only versus bolus plus continuous infusion hydromorphone for refractory cancer pain: a prospective, multicenter, randomized noninferiority trial.
Yan Z, Fu Y, Jin Y, Zhao W, Gong L, Xie G, Zhou L, Tian D, Feng Z

Bolus-only versus bolus plus continuous infusion hydromorphone for refractory cancer pain: a prospective, multicenter, randomized noninferiority trial.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Support Care Cancer.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Bolus-only versus bolus plus continuous infusion hydromorphone for refractory cancer pain: a prospective, multicenter, randomized noninferiority trial.
Author / Organization Yan Z, Fu Y, Jin Y, Zhao W, Gong L, Xie G, Zhou L, Tian D, Feng Z
Subject & Discipline Support Care Cancer
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-38817
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »